DRESS syndrome in pediatric practice: a clinical case


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

Background. DRESS (Drug Reaction with Eosinophilia and Systemic Symptoms) is a syndrome caused by a potentially life-threatening side effect to drugs with an estimated mortality of 10%. The cause of DRESS in most cases in both adults and children is anticonvulsant drugs. In the domestic literature, we did not find publications on the features of the course of DRESS in children. Description of the clinical case. The article presents a clinical case of the development of severe DRESS syndrome with fever and lung damage at the onset, severe skin syndrome and high-grade hepatitis against the background of anticonvulsant therapy in a child with newly diagnosed epilepsy. During the differential diagnostic search, allergic, infectious, incl. COVID-19 infection, and autoimmune diseases were excluded. The main treatment included the cessation of anticonvulsant therapy with replacement with less toxic drugs, the appointment of systemic corticosteroids - parenterally with the transition to oral administration and gradual withdrawal over 2 months, as well as the introduction of intravenous immunoglobulin. Against the background of the therapy, skin syndrome and cytolysis syndrome regressed. The child’s condition did not worsen, the skin syndrome did not recur, and cytolysis syndrome was not recorded during 6 month follow-up. Conclusion. The combination of episodes of febrile fever with morbilliform exanthema, the presence of lung damage according to X-ray computed tomography, acute hepatitis against the background of antiepileptic therapy during the period of a new coronavirus infection, which has a tendency to polysystemicity, was a feature of this clinical case. The complexity of the initial diagnosis was attributable to the polymorphisms of the first clinical manifestations, the rarity and insufficient awareness of specialists about the DRESS syndrome.

全文:

受限制的访问

作者简介

Aelita Kamalova

Kazan State Medical University; Children's Republican Clinical Hospital

Email: aelitakamalova@gmail.com
Dr. Sci. (Med.), Professor, Department of Hospital Pediatrics Kazan, Russia

M. Ismagilova

Children's Republican Clinical Hospital

Isolation and Diagnostic Department Kazan, Russia

G. Garina

Kazan State Medical University

Department of Hospital Pediatrics Kazan, Russia

A. Badretdinova

Kazan State Medical University

Department of Hospital Pediatrics Kazan, Russia

L. Ziyatdinova

Children's Republican Clinical Hospital

Isolation and Diagnostic Department Kazan, Russia

参考

  1. Mori F, Caffarelli C., Cammi S., et al. Drug reaction with eosinophilia and systemic symptoms (DRESS) Acta Biomed 2019;90(Suppl. 3):66-79. doi: 10.23750/abm.v90i3-S.8167.
  2. Kani Y, Shiohara T. The variable clinical picture of druginduced hypersensitivity syndrome/drug rash with eosinophilia and systemic symptoms in relation to the eliciting drug. Immunol Allergy Clin North Am. 2009;29:481-501. Doi: 10.1016/j. iac.2009.04.007.
  3. Kardaun S.H., Sekula P., Valeyrie-Allanore L., et al. Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study. Br J Dermatol. 2013;169:1071-80. doi: 10.1111/bjd.12501.
  4. Mockenhaupt M. Epidemiology of cutaneous adverse drug reactions. Allergol Select. 2017;4;1:96-1084. doi: 10.5414/ALX01508E.
  5. Choudhary S., McLeod M., Torchia D., Romanelli P. Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome. J Clin Aesthet Dermatol. 2013;6:31-7.
  6. Um S.J., Lee S.K., Kim Y.H., et al. Clinical features of drug induced hypersensitivity syndrome in 38 patients. J Investig Allergol Clin Immunol. 2010;20:556-62.
  7. Husain Z., Reddy B.Y., Schwartz R.A. DRESS syndrome: Part !!. Management therapeutics. J Am Acad Dermatol. 2013;68:709.e1-9. doi: 10.1016/j.jaad.2013.01.032.

补充文件

附件文件
动作
1. JATS XML

版权所有 © Bionika Media, 2022